This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

GABAPENTIN

Read time: 1 mins
Marketing start date: 12 Jan 2025

Summary of product characteristics


Effective Time

20240614

Version

4

Spl Product Data Elements

GABAPENTIN GABAPENTIN LACTOSE MONOHYDRATE STARCH, CORN TALC GELATIN TITANIUM DIOXIDE FERRIC OXIDE YELLOW PROPYLENE GLYCOL SHELLAC GABAPENTIN GABAPENTIN 104

Application Number

ANDA090007

Brand Name

GABAPENTIN

Generic Name

GABAPENTIN

Product Ndc

68071-4784

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

pdp

Spl Medguide

gab medguide

How Supplied

HOW SUPPLIED 100 mg Capsules (White/White colored, size 3 hard gelatin capsules with 103 printed on body of capsules containing white to off white granular powder) NDC 68071-4784-1 BOTTLES OF 100

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.